Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. UT BioHistory (TM)
Career
Job Search Post a Job Destination UT
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: CDC Get Vaccinated
Facilities
 
Advertising
 

ORCA Monthly Meeting: March 16 - Requirements & Best Practices for Management Review

Conference on Biosimilars, University of Washington, Seattle - March 19-20. Sign up today!



BioHistory Moment: Diamond v. Chakrabarty case argued before U.S. Supreme Court

Patent image

On March 17, 1980, the Diamond v. Chakrabarty case was argued before the U.S. Supreme Court regarding the patentability of genetically altered microorganisms.

In 1972, Chakrabarty filed a patent application assigned to the General Electric Co. for a human-made genetically engineered bacterium capable of breaking down multiple components of crude oil. The application asserted 36 claims related to Chakrabarty's invention of a bacterium from the genus Pseudomonas containing at least two stable energy-generating plasmids, each of said plasmids providing a separate hydrocarbon degradative pathway.

On June 16, 1980, the U.S. Supreme Court upheld five-to-four the patentability of genetically altered organisms, opening the door to greater patent protection for any modified life forms. Chief Justice Warren Burger delivered the opinion of the Court, in which justices Potter Stewart, Harry Blackmun, William Rehnquist, and John Paul Stevens joined. William Brennan filed the dissenting opinion, in which Byron White, Thurgood Marshall, and Lewis Powell joined.

More...

Learn about Sacramento's Embarcadero Road Biotech/Medical Device Facility

890 Embarcadero Road, West Sacramento, CA. The Embarcadero Road biotech/medical device facility, located just off Riverside Parkway and Interstate 80, ecompasses 425,146 square feet on 9.76 Acres. This unique facility offers office, laboratory, manufacturing, and assembly space, plus cleanrooms to address your every need. This facility is located in a state designated Enterprise Zone, and the West Sacrament Redevelopment Area/Targeted Employment Zone providing additional incentives and benefits for your company.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Utah, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • Accelrys announces latest release of Its leading discovery studio(R) application  Accelrys announced the release of Accelrys Discovery Studio(R)2.5.5, the most advanced computational chemistry and biology software application for drug discovery. This release features new algorithmic developments in the protein modeling area.
    Accelrys, Inc.  March 16, 2010  


  • Neurocrine Biosciences announces exercise of over-allotment option for common stock   Neurocrine Biosciences announced that the underwriter of its recently completed public offering of common stock has exercised in full its option to purchase an additional 1,365,000 shares of common stock to cover over-allotments with gross proceeds of approximately $23 million.
    Neurocrine Biosciences, Inc.  March 16, 2010  


  • BioTime reports publication on the reversal of the development  BioTime announced the publication of a scientific paper itled "Spontaneous Reversal of Developmental Aging in Normal Human Cells Following Transcriptional Reprogramming." The article was released online in the peer-reviewed journal Regenerative Medicine in advance of the print publication.
    BioTime, Inc.  March 16, 2010  


  • XOMA receives notice of non-compliance from NASDAQ  XOMA announced that it has received a Staff Determination letter from The NASDAQ Stock Market indicating that the company has not regained compliance with the minimum $1.00 per share requirement for continued inclusion on The NASDAQ Global Market, pursuant to NASDAQ Listing.
    XOMA Ltd.  March 16, 2010  


  • Founder of UCLA's Jonsson Comprehensive Cancer Center dead at 79  Kenneth A. Jonsson, who along with his late wife, Diana, helped to found UCLA's Jonsson Comprehensive Cancer Center, died March 15 at his Pacific Palisades home. He was 79. Jonsson made his first donation to support cancer research more than four decades ago in the 1960s.
    Jonsson Comprehensive Cancer Center   March 16, 2010  


More... | Submit News Release | Advertising...

News

New Job Postings...

Free Job Posting Trial Offer
  • Senior Quality Assurance Specialist, Compliance Bend Research Pharmaceutical Process Development (OR)
  • Drug Development Associate Project Manager Seattle Genetics, Inc. (WA)
  • Corporate Communications Specialist Seattle Genetics, Inc. (WA)
  • Scientist/Senior Scientist, Formulations Seattle Genetics, Inc. (WA)
  • Quality Assurance Validation Associate Seattle Genetics, Inc. (WA)
More... | Job Advertising... | About Job Postings...
Master's Degree in Biomedical Regulatory Affairs

New Facilities Available...

ATC clean room constructors...validation guaranteed!
  • 890 Embarcadero Road Property -- West Sacramento, CA
  • CompleGen Lab/Office Space -- Seattle, WA
  • Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
Facilities

Upcoming Events...

  • 03/17/2010: 7th Annual Investor & Entrepreneur Roundtables
  • 03/17/2010: Audio Conference - Clinical Trial Agreement Indemnification Clauses: Protect Your Interests, Get Approval
  • 03/17/2010: Pharmacovigilance Inspections: A Practical Approach
  • 03/17/2010: Superbugs and Superdrugs - Overcoming Resistance
  • 03/17/2010: Online Webinar: Evaluating Clinical Sites
More... | Submit Event | Event Advertising...
Master's Degree in Biomedical Regulatory Affairs

Learn About Utah's BioHistory

Learn About Utah's BioHistory Why is there a life science industry in Utah? Is the industry growing? What do other states have?

Through Utah BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Utah.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


March - National Colorectal Cancer Awareness Month

National Colorectal Cancer Awareness Month

As a leading health organization for 25 years, the Prevent Cancer Foundation, the vision of Carolyn Aldigé, has catapulted cancer prevention to prominence and provided more than $113 million in support of cancer prevention and early detection research, education and community outreach programs across the country.

More...


BioFact

(1983) - The U.S. National Plant Germplasm System's total budget is just over $10 million. This amounts to .02% of the USDA's total budget for 1983 and is 500 times less than the 10% the USDA spent on comparable activities in 1921.


It's a Small World

  Dendrite Dendrite  

Science Quote

"Science is a wonderful thing if one does not have to earn one's living at it."

-  Albert Einstein
 (1879-1955)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

UtahLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of Utah.